April 15, 2025
Obesity treatment path: Addressing supply chain challenges for GLP-1 medicines
The landscape of obesity treatment is transforming with the arrival of the highly effective medications, offering benefits far beyond weight loss. Glucagon-like peptide-1 (GLP-1) receptors, like Wegovy, Ozempic and Mounjaro, have shown excellent weight loss results in the obesity treatment market. However, the current cost of these drugs is relatively expensive, making them financially inaccessible…
managementconsulting